Treating multiple sclerosis with generic cladribine

被引：0
|
作者：
Alvarez-Gonzalez, C. [1 ,2 ]
Allen-Philbey, K. [2 ]
Mathews, J. [3 ]
Espasandin, M. [2 ]
Turner, B. P. [1 ,2 ]
Gnanapavan, S. [1 ,2 ]
Marta, M. [1 ,2 ]
Giovannoni, G. [1 ,2 ]
Baker, D. [1 ]
Schmierer, K. [1 ,2 ]
机构：
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Neurosci, London, England
[2] Barts Hlth NHS Trust, Emergency Care & Acute Med Neurosci Clin Acad Grp, London, England
[3] Barts Hlth NHS Trust, Neurol & Med Safety, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1161
引用
收藏
页码：604 / 605
页数：2
相关论文
共 50 条
  • [31] Cladribine - A review of its use in multiple sclerosis
    Langtry, HD
    Lamb, HM
    BIODRUGS, 1998, 9 (05) : 419 - 433
  • [32] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Gavin Giovannoni
    Neurotherapeutics, 2017, 14 : 874 - 887
  • [33] The treatment of chronic progressive multiple sclerosis with cladribine
    Beutler, E
    Sipe, JC
    Romine, JS
    Koziol, JA
    McMillan, R
    Zyroff, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1716 - 1720
  • [34] Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
    Biernacki, Tamas
    Sandi, Daniel
    Bencsik, Krisztina
    Vecsei, Laszlo
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (04) : 269 - 285
  • [35] Development of oral cladribine for the treatment of multiple sclerosis
    Hans-Peter Hartung
    Orhan Aktas
    Bernd Kieseier
    Giancarlo Comi
    Journal of Neurology, 2010, 257 : 163 - 170
  • [36] PERSONALISED DOSING OF CLADRIBINE TO TREAT MULTIPLE SCLEROSIS
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Allen-Philbey, Kimberley
    Mathews, Joela
    Turner, Benjamin P.
    Gnanapavan, Sharmilee
    Marta, Monica
    Baker, David
    Giovannoni, Gavin
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A47 - A48
  • [37] Clinical practice experience with cladribine in multiple sclerosis
    Meca-Lallana, V.
    Aguirre, C.
    Torres, J.
    Diaz, C.
    Del Rio, B.
    Martin, R.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 138 - 139
  • [38] Personalised dosing of cladribine for people with multiple sclerosis
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Yildiz, Ozlem
    Allen-Philbey, Kimberley
    Turner, Benjamin
    Gnananpavan, Sharmilee
    Marta, Monica
    Mathews, Joela
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    NEUROLOGY, 2018, 90
  • [39] Cladribine Tablets' Potential in Multiple Sclerosis Treatment
    Costello, Kathleen
    Sipe, Jack C.
    JOURNAL OF NEUROSCIENCE NURSING, 2008, 40 (05) : 275 - 280
  • [40] CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    Pakpoor, Julia
    Disanto, Giulio
    Altmann, Daniel R.
    Pavitt, Sue
    Turner, Benjamin
    Calado-Marta, Monica
    Juliusson, Gunnar
    Baker, David
    Chataway, Jeremy
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
12345